These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 4559395)
1. Parkinsonism, levodopa, and anesthesia. Ngai SH Anesthesiology; 1972 Sep; 37(3):344-51. PubMed ID: 4559395 [No Abstract] [Full Text] [Related]
2. Levodopa and amantadine in the treatment of Parkinsonism. Critchley E Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037 [No Abstract] [Full Text] [Related]
3. Recent advances in the treatment of Parkinsonism with drugs. Rinne UK Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076 [No Abstract] [Full Text] [Related]
4. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism. Brogden RN; Speight TM; Avery GS Drugs; 1971; 2(4):262-400. PubMed ID: 4340597 [No Abstract] [Full Text] [Related]
6. Levodopa and related drugs. Med Lett Drugs Ther; 1973 Mar; 15(5):21-3. PubMed ID: 4697470 [No Abstract] [Full Text] [Related]
7. Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Parkes JD; Baxter RC; Curzon G; Knill-Jones RP; Knott PJ; Marsden CD; Tattersall R; Vollum D Lancet; 1971 May; 1(7709):1083-6. PubMed ID: 4102620 [No Abstract] [Full Text] [Related]
8. Start hesitation--a side effect of long-term levodopa therapy. Ambani LM; Van Woert MH N Engl J Med; 1973 May; 288(21):1113-5. PubMed ID: 4697941 [No Abstract] [Full Text] [Related]
9. Rigidity and pulmonary edema after Innovar in a patient on Levodopa therapy: report of a case. Wiklund RA; Ngai SH Anesthesiology; 1971 Nov; 35(5):545-7. PubMed ID: 5098709 [No Abstract] [Full Text] [Related]
11. L-dopa in the treatment of parkinsonism. Haleem MA Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915 [No Abstract] [Full Text] [Related]
12. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease. Parkes JD; Baxter RC; Marsden CD; Rees JE J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913 [TBL] [Abstract][Full Text] [Related]
13. Theoretical implications of the use of L-dopa in parkinsonism. A review. Klawans H; Ilahi MM; Shenker D Acta Neurol Scand; 1970; 46(4):409-41. PubMed ID: 4323341 [No Abstract] [Full Text] [Related]
14. Permanent dementia in idiopathic Parkinsonism treated with levodopa. Wolf SM; Davis RL Arch Neurol; 1973 Oct; 29(4):276-8. PubMed ID: 4728189 [No Abstract] [Full Text] [Related]
15. Comparison of amantadine, placebo, and levodopa in Parkinson's disease. Bauer RB; McHenry JT Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417 [No Abstract] [Full Text] [Related]